1. Home
  2. SGN vs AEMD Comparison

SGN vs AEMD Comparison

Compare SGN & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Signing Day Sports Inc.

SGN

Signing Day Sports Inc.

HOLD

Current Price

$0.17

Market Cap

2.4M

Sector

N/A

ML Signal

HOLD

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$3.17

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGN
AEMD
Founded
2019
1984
Country
United States
United States
Employees
9
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SGN
AEMD
Price
$0.17
$3.17
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$287.50
AVG Volume (30 Days)
29.7M
70.4K
Earning Date
11-12-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$366,344.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$2.22
52 Week High
$7.24
$64.00

Technical Indicators

Market Signals
Indicator
SGN
AEMD
Relative Strength Index (RSI) 24.45 55.77
Support Level $0.11 $2.64
Resistance Level $0.19 $3.19
Average True Range (ATR) 0.10 0.30
MACD -0.02 0.10
Stochastic Oscillator 9.56 87.96

Price Performance

Historical Comparison
SGN
AEMD

About SGN Signing Day Sports Inc.

Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: